What We Do
Cancer in our kids. A nightmare too true for too many. Including Sebastian. His fight showed us what life really means, and what truly matters. We keep fighting for him.
As such, our core purpose is to find more targeted, less toxic treatments for pediatric cancers while easing the burdens kids and families face.
We fund early stage, cutting edge research through our annual Discovery Science Award. To date, we’ve granted over $2M for pediatric cancer research at institutions including Yale, University of Colorado, Albert Einstein Medical College, Johns Hopkins, and Children’s Hospital of Philadelphia. To best determine what research projects to fund, we work closely with our medical advisory board, which is comprised of some of the top pediatric cancer doctors in the country.
Our approach is to focus on promising research that would not be funded otherwise. We do so through collaboration with leading researchers and other childhood cancer foundations. We strive to deliver hope for children and families facing a cancer diagnosis.
2022 SEBASTIANSTRONG DISCOVERY SCIENCE AWARD
Focused Ultrasound Consortium for Treatment of Children Diagnosed With Diffuse Midline Gliomas
–More Info Forthcoming
2021 SEBASTIANSTRONG DISCOVERY SCIENCE AWARD
Multi-Antigen Specific CAR T Cells as a Novel Therapy for Relapsed/Refractory Acute Myeloid Leukemia (AML)
2020 SEBASTIANSTRONG DISCOVERY SCIENCE AWARD
Exploiting Metabolic Defects with NAMPT Inhibitors in DIPG – Read More
2020 SEBASTIANSTRONG RESEARCH GRANT
Computational Approaches for Identifying Effective Treatments for Pediatric Brain Tumors – Read More
2019 SEBASTIANSTRONG DISCOVERY SCIENCE AWARDS
Targeting the Tumor Microenvironment of Metastasis to Treat Metastatic Ewing Sarcoma – Read More
Re-purposing HIV Nucleoside Reverse Transcriptase Inhibitors for High-Risk Neuroblastoma Therapy – Read More
2019 OUTSMARTING OSTEOSARCOMA AWARD (in partnership with MIB Agents)
New Immune-mediated Therapies for Lung Osteosarcoma – Read More
2018 YOUNG INVESTIGATOR GRANTS
Augmenting Chimeric Antigen Receptor T Cell Induced Epitope Spreading for Pediatric Solid Tumors – Read More
Targeting Glutamine Metabolism in MYC Driven Atypical Teratoid Rhabdoid Tumors – Read More
2018 SEBASTIANSTRONG RESEARCH GRANT
Clinical Trial of Disulfram to Overcome Chemotherapy Resistance In Sarcomas – Read More
Apply for Funding
Applications for the 2023 Discovery Science Award are now being accepted!
January 31, 2023 – Lay Summary/Proposed Research Due
Thank you for your interest in the Discovery Science Award. Before applying, please review our Funded Projects section above to see previous recipients and the research we’ve funded. Our application process is powered by InfoReady.
To submit your application, click HERE! That will take you to the InfoReady Portal. Once there, open the “2023 Discovery Science Award Guidelines” documents. It details the application process and offers you the opportunity to watch a short video that explains how to get started.
If you have any questions, please email firstname.lastname@example.org